Difference between revisions of "PSMB8-AS1"
(Created page with "The aberrant expression of PSMB8-AS1 is highly relevant to glioma tumorigenesis and prognosis of GBM patients.<ref name="ref1" /> ==Annotated Information== ===Name===...") |
|||
Line 1: | Line 1: | ||
− | + | LncRNA PSMB8-AS1 acts as miR-22-3p sponge to mediate DDIT4 expression and regulate glioblastoma progression.<ref name="ref1" /> | |
==Annotated Information== | ==Annotated Information== | ||
===Name=== | ===Name=== | ||
Line 6: | Line 6: | ||
Approved name:PSMB8 antisense RNA 1 (head to head) | Approved name:PSMB8 antisense RNA 1 (head to head) | ||
− | HGNC ID | + | HGNC ID:39758 |
Previous name:TAP1 and PSMB8 antisense RNA 1 | Previous name:TAP1 and PSMB8 antisense RNA 1 | ||
Line 18: | Line 18: | ||
Prev_symbol:TAPSAR1 | Prev_symbol:TAPSAR1 | ||
===Characteristics=== | ===Characteristics=== | ||
− | PSMB8-AS1 | + | PSMB8-AS1 distributed in nucleus and cytoplasm of GBM cells.<ref name="ref1" /> |
===Function=== | ===Function=== | ||
− | PSMB8-AS1 | + | PSMB8-AS1 regulates GBM cell proliferation, apoptosis and radioresistance.<ref name="ref1" /> |
===Regulation=== | ===Regulation=== | ||
− | + | Overexpression of PSMB8-AS1 promoted the level of DDIT4 through inhibiting miR-22-3p.<ref name="ref1" /> <ref name="ref1" /> | |
− | ===Expression=== | + | ===Expression=== |
+ | [[File: PSMB8-AS1.gif|thumb|300px| Relative expressions of PSMB8-AS1 in 30 GBM tissues and paired | ||
+ | noncancerous tissues determined by RT-qPCR.<ref name="ref1"/>]] | ||
High expression trends of lncRNA PSMB8-AS1 was observed in both glioblastoma tissues and cells. <ref name="ref1" /> | High expression trends of lncRNA PSMB8-AS1 was observed in both glioblastoma tissues and cells. <ref name="ref1" /> | ||
===Diseases=== | ===Diseases=== | ||
Line 33: | Line 35: | ||
*Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, Shandong, 272029, China. Electronic address: hanguangkui1997@163.com.<ref name="ref1" /> | *Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, Shandong, 272029, China. Electronic address: hanguangkui1997@163.com.<ref name="ref1" /> | ||
− | ==References== | + | ==References== |
+ | <references> | ||
<ref name="ref1">Hu T, Wang F, Han G. LncRNA PSMB8-AS1 acts as ceRNA of miR-22-3p to regulate DDIT4 expression in glioblastoma. Neurosci Lett. 2020 May 29;728:134896. doi: 10.1016/j.neulet.2020.134896. Epub 2020 Mar 6.</ref>(1) | <ref name="ref1">Hu T, Wang F, Han G. LncRNA PSMB8-AS1 acts as ceRNA of miR-22-3p to regulate DDIT4 expression in glioblastoma. Neurosci Lett. 2020 May 29;728:134896. doi: 10.1016/j.neulet.2020.134896. Epub 2020 Mar 6.</ref>(1) | ||
</references> | </references> |
Revision as of 03:51, 19 February 2021
LncRNA PSMB8-AS1 acts as miR-22-3p sponge to mediate DDIT4 expression and regulate glioblastoma progression.[1]
Contents
Annotated Information
Name
Approved symbol:PSMB8-AS1
Approved name:PSMB8 antisense RNA 1 (head to head)
HGNC ID:39758
Previous name:TAP1 and PSMB8 antisense RNA 1
Alias symbol:XXbac-BPG246D15.8|TAP1-AS1
RefSeq ID:NR_037173
LncBook ID:HSALNG0049455
Prev_symbol:TAPSAR1
Characteristics
PSMB8-AS1 distributed in nucleus and cytoplasm of GBM cells.[1]
Function
PSMB8-AS1 regulates GBM cell proliferation, apoptosis and radioresistance.[1]
Regulation
Overexpression of PSMB8-AS1 promoted the level of DDIT4 through inhibiting miR-22-3p.[1] [1]
Expression
High expression trends of lncRNA PSMB8-AS1 was observed in both glioblastoma tissues and cells. [1]
Diseases
Glioblastoma (GBM)[1]
Labs working on this lncRNA
- Department of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, 030012, China.[1]
- Department of Neurosurgery, Heze Municipal Hospital, Heze, Shandong, 274033, China.[1]
- Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, Shandong, 272029, China. Electronic address: hanguangkui1997@163.com.[1]